Analyst Price Targets — TECH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 5, 2026 12:58 pm | — | Stifel Nicolaus | $65.00 | $67.64 | TheFly | Bio-Techne price target raised to $65 from $60 at Stifel |
| February 5, 2026 12:34 pm | — | UBS | $79.00 | $68.67 | TheFly | Bio-Techne price target raised to $79 from $70 at UBS |
| February 5, 2026 12:22 pm | — | Robert W. Baird | $70.00 | $68.67 | TheFly | Bio-Techne price target raised to $70 from $61 at Baird |
| January 5, 2026 11:22 am | — | Evercore ISI | $62.00 | $59.65 | TheFly | Bio-Techne downgraded to In Line from Outperform at Evercore ISI |
| December 12, 2025 2:07 pm | Justin Bowers | Deutsche Bank | $72.00 | $59.67 | TheFly | Bio-Techne price target raised to $72 from $66 at Deutsche Bank |
| November 20, 2025 2:40 pm | — | Argus Research | $68.00 | $58.64 | TheFly | Bio-Techne price target raised to $68 from $65 at Argus |
| November 6, 2025 5:42 pm | — | Evercore ISI | $68.00 | $58.40 | TheFly | Bio-Techne price target lowered to $68 from $72 at Evercore ISI |
| September 2, 2025 8:09 pm | Conor McNamara | RBC Capital | $73.00 | $53.42 | TheFly | Bio-Techne upgraded to Outperform at RBC on forecast multiple expansion |
| March 17, 2025 8:21 pm | — | Evercore ISI | $75.00 | $62.58 | TheFly | Bio-Techne initiated with an Outperform at Evercore ISI |
| October 31, 2024 7:11 am | Catherine Schulte | Robert W. Baird | $84.00 | $76.02 | StreetInsider | Bio-Techne Corp. (TECH) PT Raised to $84 at Baird |
Latest News for TECH
Bio-Techne Corporation (TECH) Q3 2026 Earnings Call Transcript
Bio-Techne slips after Q3 EPS miss and revenue decline, despite operating margin expansion and strong growth in key segments.
Techne (TECH) came out with quarterly earnings of $0.53 per share, missing the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.56 per share a year ago.
Biotech firm Bio-Techne on Wednesday missed Wall Street estimates for third-quarter revenue, as cuts to U.S. academic funding weighed on demand for its drug-development products.
MINNEAPOLIS, May 6, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended March 31, 2026. The quarterly dividend will be payable May 29, 2026, to all common shareholders of record on May 18, 2026.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.